Tamsulosin 0.4 mg once daily:: Effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

被引:96
作者
Höfner, K
Claes, H
De Reijke, TM
Folkestad, B
Speakman, MJ
机构
[1] Med Hsch Hannover, Hannover, Germany
[2] St Jan Ziekenhuis, Brussels, Belgium
[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Sjukhuset, Linkoping, Sweden
[5] Taunton & Somerset Hosp, Taunton, Somerset, England
关键词
lower urinary tract symptoms; benign prostatic obstruction; alpha(1A)-adrenoceptor antagonist; sexual function; tamsulosin;
D O I
10.1159/000019996
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexual function in comparison with placebo and alfuzosin, 2.5 mg three times daily, in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO). Methods: Data from 830 patients randomized into three European multicenter studies with similar protocols were analyzed. In two studies, patients were randomized to receive either tamsulosin, 0.4 mg once daily, or placebo, and in the third, patients were randomized to receive either a fixed dose of tamsulosin, 0.4 mg once daily, or alfuzosin, titrated to 2.5 mg three times daily. The studies employed a 2-week placebo run-in period, followed by a 12-week study period. Sexual function was assessed by related adverse events and by a sexual function score determined from a life-style questionnaire. Results: Abnormal ejaculation occurred significantly more frequently in patients treated with tamsulosin than in those receiving placebo (p = 0.045); however, the incidence of abnormal ejaculation was similar in patients receiving tamsulosin or alfuzosin in the comparative study. Abnormal ejaculation was not perceived as a major problem by the patients since it resulted in few treatment discontinuations (n = 3). It was also reversible on drug withdrawal. There was no difference between tamsulosin and placebo or alfuzosin with regard to the occurrence of decreased libido or impotence. In addition, there was no significant difference in the change in sexual function score between patients treated with tamsulosin and those treated with alfuzosin. Compared with patients receiving placebo, there was, however, a significant improvement in total sexual function score in patients receiving tamsulosin (p = 0.042). Conclusions: Tamsulosin, 0.4 mg once daily, is well tolerated and has no overall negative impact on sexual function compared with placebo or alfuzosin. Compared with placebo, tamsulosin may even improve sexual function.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 47 条
[1]   TAMSULOSIN, A SELECTIVE ALPHA(1C)-ADRENOCEPTOR ANTAGONIST - A RANDOMIZED, CONTROLLED TRIAL IN PATIENTS WITH BENIGN PROSTATIC OBSTRUCTION (SYMPTOMATIC BPH) [J].
ABRAMS, P ;
SCHULMAN, CC ;
VAAGE, S ;
ABEL, P ;
BAXBY, K ;
BOEMINGHAUS, F ;
DELAERE, KPJ ;
DENIS, L ;
DIJKMAN, GA ;
HASSELLUND, S ;
HOHENFELLNER, R ;
JANKNEGT, RA ;
KAPPER, BJ ;
KARTHAUS, HFM ;
KHOE, GSS ;
KIL, PJM ;
KROMANNANDERSEN, B ;
LELIEFELD, HHJ ;
LOCK, TMTW ;
MOHR, M ;
MOMMSEN, S ;
OGREID, P ;
OTTO, RW ;
PLASMAN, JWMH ;
PULL, HC ;
RYTTOV, N ;
TOLLEY, DA ;
VENEMA, PL ;
WYNDAELE, JJ ;
YPMA, AFGVM .
BRITISH JOURNAL OF UROLOGY, 1995, 76 (03) :325-336
[2]   MANAGING LOWER URINARY-TRACT SYMPTOMS IN OLDER MEN [J].
ABRAMS, P .
BRITISH MEDICAL JOURNAL, 1995, 310 (6987) :1113-1117
[3]   Neurotransmission and the contraction and relaxation of penile erectile tissues [J].
Andersson, KE ;
Stief, CG .
WORLD JOURNAL OF UROLOGY, 1997, 15 (01) :14-20
[4]   Oral phentolamine as treatment for erectile dysfunction [J].
Becker, AJ ;
Stief, CG ;
Machtens, S ;
Schultheiss, D ;
Hartmann, U ;
Truss, MC ;
Jonas, U .
JOURNAL OF UROLOGY, 1998, 159 (04) :1214-1215
[5]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[6]  
Boyarsky S, 1976, Trans Am Assoc Genitourin Surg, V68, P29
[7]   Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia) [J].
Buzelin, JM ;
Fonteyne, E ;
Kontturi, M ;
Witjes, WPJ ;
Khan, A .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (04) :597-605
[8]  
CAINE M, 1990, UROL CLIN N AM, V17, P641
[9]   A 12-WEEK PLACEBO-CONTROLLED STUDY OF PRAZOSIN IN THE TREATMENT OF PROSTATIC OBSTRUCTION [J].
CHAPPLE, CR ;
CHRISTMAS, TJ ;
MILROY, EJG .
UROLOGIA INTERNATIONALIS, 1990, 45 :47-55
[10]  
Chapple CR, 1996, EUR UROL, V29, P155